2022-Ra-653-Esgo The Impact of Histology, Prior Therapy, and Dmmr Status on Lenvatinib + Pembrolizumab Outcomes in Patients with Advanced Endometrial Cancer: A Subgroup Analysis of Study 309/Keynote-775
AuthID
P-00Y-VYM
P-00Y-VYM